• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Daniel Keizman, Maya Gottfried, +11 authors Avishay Sella
  • Medicine
  • The oncologist
  • 2012 (First Publication: 1 December 2012)
  • BACKGROUND The neutrophil-to-lymphocyte ratio (NLR), an inflammation marker, is prognostic in several cancers. We assessed the association between the pretreatment NLR and outcome of patients withContinue Reading
  • Daniel Keizman, Maya Ish-shalom, +12 authors Michael Anthony Carducci
  • Medicine
  • European journal of cancer
  • 2012 (First Publication: 1 May 2012)
  • BACKGROUND Bisphosphonates are used to prevent skeletal events of bone metastases, and may exhibit antitumour effects. We aimed to evaluate whether bisphosphonates can bring a response rate (RR),Continue Reading
  • Daniel Keizman, Maya Ish-shalom, +4 authors Avishay Sella
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2012 (First Publication: 10 February 2012)
  • 37 Background: The CYP17 inhibitor Keto is active in mCRPC. The NLR, an index of systemic inflammation, is associated with prognosis in several types of cancer. We assessed the association betweenContinue Reading
  • Dana Livne-Segev, Maya Gottfried, +11 authors Daniel Keizman
  • Medicine
  • The Israel Medical Association journal : IMAJ
  • 2014 (First Publication: 1 June 2014)
  • BACKGROUND The VEGFR/PDGFR inhibitor sunitinib was approved in Israel in 2008 for the treatment of metastatic renal cell carcinoma (mRCC), based on an international trial. However, the efficacy ofContinue Reading